[Diagnostic and physiopathological innovations related to chronic urticaria].
Bérard
Frédéric
F
Service d'Immunologie Clinique et Allergologie, CHU Lyon Sud et Inserm U851, Pierre Bénite cedex, France. frederic.berard@chu-lyon.fr
Boulinguez
Serge
S
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001323:Autoantibodies / Q000097:blood; D001327:Autoimmune Diseases / Q000175:diagnosis; D001777:Blood Coagulation / Q000502:physiology; D002908:Chronic Disease; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D039563:Histamine H1 Antagonists, Non-Sedating / Q000627:therapeutic use; D006636:Histamine Release; D006801:Humans; D007453:Iodide Peroxidase / Q000276:immunology; D017336:Loratadine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008407:Mast Cells / Q000378:metabolism; D008875:Middle Aged; D000069444:Omalizumab; D010406:Penicillins / Q000009:adverse effects; D014581:Urticaria / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001323:Autoantibodies; D039563:Histamine H1 Antagonists, Non-Sedating; D010406:Penicillins; D000069444:Omalizumab; D017336:Loratadine; D007453:Iodide Peroxidase; C121345:desloratadine